BR0013574A - Antìgeno vacina de moraxella - Google Patents

Antìgeno vacina de moraxella

Info

Publication number
BR0013574A
BR0013574A BR0013574-7A BR0013574A BR0013574A BR 0013574 A BR0013574 A BR 0013574A BR 0013574 A BR0013574 A BR 0013574A BR 0013574 A BR0013574 A BR 0013574A
Authority
BR
Brazil
Prior art keywords
moraxella
vaccine
old
antigen
antigens
Prior art date
Application number
BR0013574-7A
Other languages
English (en)
Inventor
Jacinta Farn
Richard Strugnell
Jan Tennent
Original Assignee
Commw Scient Ind Res Org
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commw Scient Ind Res Org, Univ Melbourne filed Critical Commw Scient Ind Res Org
Publication of BR0013574A publication Critical patent/BR0013574A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Abstract

"ANTìGENO VACINA DE MORAXELLA". A presente invenção relata um antígeno de Moraxella, em particular, Moraxella bovis, uma seq³ência de ácido nucléico codificando esses antígenos e formulações para uso na criação de uma resposta imune contra a Moraxella.
BR0013574-7A 1999-08-31 2000-08-31 Antìgeno vacina de moraxella BR0013574A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ2571A AUPQ257199A0 (en) 1999-08-31 1999-08-31 Vaccine antigens of moraxella
PCT/AU2000/001048 WO2001016172A1 (en) 1999-08-31 2000-08-31 Vaccine antigens of moraxella

Publications (1)

Publication Number Publication Date
BR0013574A true BR0013574A (pt) 2002-06-11

Family

ID=3816742

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013574-7A BR0013574A (pt) 1999-08-31 2000-08-31 Antìgeno vacina de moraxella

Country Status (7)

Country Link
US (2) US7018639B1 (pt)
EP (1) EP1210364A4 (pt)
CN (1) CN1377369A (pt)
AU (1) AUPQ257199A0 (pt)
BR (1) BR0013574A (pt)
CA (1) CA2383557A1 (pt)
WO (1) WO2001016172A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7220421B2 (en) * 2001-06-19 2007-05-22 The Regents Of The University Of California Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections
EP2292743B1 (en) 2003-12-03 2013-08-21 Danisco US Inc. Perhydrolase
EP3289098B1 (en) * 2015-04-30 2024-03-20 Sakura Finetek U.S.A., Inc. Methods to reduce evaporation during elevated temperature
CN107614702A (zh) * 2016-04-15 2018-01-19 包埋剂技术美国股份有限公司 在升高的温度下减少蒸发的方法
CN115960184B (zh) * 2022-09-28 2023-12-12 华中农业大学 一种溶血性曼氏杆菌a6血清型白细胞毒素抗原蛋白、其抗体及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675176A (en) 1983-12-12 1987-06-23 Norden Laboratories Moraxella bovis protease vaccine
AU5088690A (en) * 1989-01-06 1990-08-01 Regents Of The University Of California, The Keratoconjunctivitis cytotoxin and methods for its use and production
US5594107A (en) * 1990-08-22 1997-01-14 University Of Saskatchewan Chimeric protein comprising an RTX-family cytotoxin and interferon-2 or interferon

Also Published As

Publication number Publication date
CN1377369A (zh) 2002-10-30
CA2383557A1 (en) 2001-03-08
AUPQ257199A0 (en) 1999-09-23
WO2001016172A1 (en) 2001-03-08
US7018639B1 (en) 2006-03-28
US20060257417A1 (en) 2006-11-16
EP1210364A1 (en) 2002-06-05
EP1210364A4 (en) 2004-07-21

Similar Documents

Publication Publication Date Title
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
RS51157B (sr) Baff receptor (bcma), imunoregulatorni agens
ATE315405T1 (de) Cpg-zusammensetzungen, saponin-adjuvantien und verfahren zu deren verwendung
CY1111325T1 (el) Πολυεπιτοπικη πρωτεϊνη-φορεας
CY1106350T1 (el) Εμβολιο φυματιωσης
ATE446368T1 (de) Antigene aus neisseria meningitidis
NZ503763A (en) Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use
WO2005037190A3 (en) Multiplex vaccines
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
BR9712971A (pt) Método para produção de uma vacina para proteção de um hospedeiro contra doença causada com uma cadeia de chlamydia e composição imunológica
DK0957935T3 (da) Chlamydia-vacciner og immunogene præparater indeholdende et ydre membran-antigen samt fremgangsmåde til fremstilling deraf
PT807178E (pt) Proteinas de micobacterias, microrganismos que as produzem e suas utilizacoes vacinicas e para a deteccao da tuberculose
DK0588578T3 (da) Immunogener
DE60139963D1 (de) Fusionsproteine aus mycobakterium tuberculosis
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
CY1105604T1 (el) Μεθοδος ενισχυσης ανοσων απαντησεων στο εμβολιο κατα του ιου του απλου ερπητα
DK1259259T3 (da) Mucosal adjuvansformulering
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
ES2177927T3 (es) Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.
BR0011469A (pt) Gm-csf equina
AU2001284354A1 (en) Immunological adjuvant compounds, compositions, and methods of use thereof
BR0013574A (pt) Antìgeno vacina de moraxella
BR9710849A (pt) Vacina contendo uma peróxi-redoxina e/ou uma beta-tubulina.
BR0115646A (pt) Composição, dispositivo de liberação de partìculas, uso de uma composição, e, método para intensificar uma resposta imune contra um antìgeno de interesse em um paciente
DE60239753D1 (de) Impfstoff gegen infektiöses lachsanämievirus

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]